Global Plasma Fractionation Market Overview 2023-2028
IMARC Group, a leading market research company, has recently releases report titled “Plasma Fractionation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global plasma fractionation market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global plasma fractionation market size reached US$ 23.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.
Plasma fractionation is the process of separating plasma into its distinct components, including proteins, clotting factors, and immunoglobulins. This procedure plays a crucial role in securing a consistent supply of essential plasma-derived medications, significantly contributing to the overall well-being of patients. By isolating and refining specific plasma proteins, plasma fractionation serves therapeutic and medical purposes. This method is indispensable in addressing conditions such as severe bleeding or clotting disorders, providing vital support in critical care situations, and aiding in stabilizing patients during medical emergencies. Furthermore, plasma fractionation is essential in developing therapies for neurological disorders like Alzheimer’s disease, multiple sclerosis, and Guillain-Barré syndrome. It holds a pivotal role in the treatment of rare and orphan diseases, offering valuable options for individuals with conditions that have limited treatment alternatives. In the realm of medical research, plasma fractionation supports studies and experiments by providing purified plasma components, leading to advancements in understanding diseases and the development of novel treatments. It proves beneficial in cases of burn injuries and trauma by maintaining proper fluid balance, promoting clotting, and supporting tissue repair. By reducing the risk of medicine shortages, plasma fractionation ensures that patients with chronic conditions have consistent access to the therapies they require. The increasing demand for plasma fractionation worldwide is driven by its positive impact on enhancing the chances of survival for patients with various diseases.
Request a Sample Report:- https://www.imarcgroup.com/plasma-fractionation-market/requestsample
Global Plasma Fractionation Market Trends and Drivers:
The global market is experiencing a surge in the adoption of plasma fractionation for the treatment of various medical conditions, including hemophilia, autoimmune diseases, and neurological disorders. This widespread adoption is a key driver for the market’s current growth trajectory. The increasing demand for plasma-derived therapies, such as convalescent plasma for treating infectious diseases, is contributing positively to market expansion. Moreover, there is a growing emphasis on early disease detection, further boosting the market. The market is also benefitting from the rising use of advanced plasma fractionation equipment that enhances efficiency while reducing costs. Additionally, there is a heightened demand for plasma fractionation to develop therapies for rare and orphan diseases. This trend is reinforced by the improving healthcare infrastructure worldwide. Advances in plasma fractionation techniques and technologies are playing a crucial role in creating safer, more efficient, and higher-quality plasma-derived products, thereby propelling market growth. Furthermore, increased awareness among healthcare professionals and patients about the efficacy of plasma-derived therapies is creating lucrative growth opportunities for industry investors. The market is also positively influenced by the growing demand for plasma fractionation due to the rising incidence of age-related conditions, such as Alzheimer’s disease and certain neurological disorders, necessitating plasma-derived treatments. Governmental promotion of voluntary blood donation campaigns in numerous countries is an additional factor contributing to the market’s expansion.
Global Plasma Fractionation Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: ADMA Biologics, Bio Products Laboratory Ltd., Boccard, Grifols, S.A., Hemarus Therapeutics Limited, Intas Pharmaceuticals Limited, LFB S.A., Merck Group, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., SK Plasma Co. Ltd. and Virchow Biotech Private Limited
The report segmented the market on the basis of region, product, sector, application and end user.
Breakup by Product:
- Immunoglobulins
- Albumin
- Coagulation factor VIII
- Coagulation factor IX
Breakup by Sector:
- Private Sector
- Public Sector
Breakup by Application:
- Neurology
- Immunology
- Hematology
- Other Applications
Breakup by End User:
- Hospitals and Clinics
- Clinical Research Laboratories
- Academic Institutes
Breakup By Regions:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
